Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Veronika Sexl, Andrea Hoelbl‐Kovacic et al.|Blood|2018Cited by 155
Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activityFranz Ratzinger, Klaus G. Schmetterer|Scientific Reports|2014Cited by 111